Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantheus

79.19
+0.20000.25%
Post-market: 78.25-0.9400-1.19%16:48 EDT
Volume:1.54M
Turnover:121.62M
Market Cap:5.48B
PE:22.43
High:80.30
Open:79.36
Low:78.11
Close:78.99
Loading ...

Lantheus Holdings Q1 Adj. EPS $1.53 Misses $1.66 Estimate, Sales $372.64M Miss $379.02M Estimate

Benzinga
·
07 May

Stock Track | Lantheus Shares Plunge 6.52% Pre-Market as Q1 Earnings Miss Estimates

Stock Track
·
07 May

Stock Track | Lantheus Plunges 6.52% Pre-market as Q1 Earnings Miss Estimates

Stock Track
·
07 May

BRIEF-Lantheus Holdings Q1 Adjusted EPS USD 1.53 Vs. IBES Estimate USD 1.66

Reuters
·
07 May

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
07 May

Lantheus Holdings Q1 Free Cash Flow USD 98.8 Million

THOMSON REUTERS
·
07 May

Lantheus Holdings Q1 Adjusted EPS USD 1.53 VS. Ibes Estimate USD 1.66

THOMSON REUTERS
·
07 May

Lantheus Holdings - Outlook FY Adjusted Fully Diluted EPS$6.60 - $6.70

THOMSON REUTERS
·
07 May

Lantheus Holdings - Outlook FY REV $1.550 Billion - $1.585 Billion

THOMSON REUTERS
·
07 May

Lantheus to Sell Nuclear-Imaging Test Unit

Dow Jones
·
07 May

Lantheus Holdings Inc - to Receive Cash Payment and Note Convertible Into Shine Preferred Stock

THOMSON REUTERS
·
07 May

Lantheus Announces Sale of Spect Business to Shine Technologies

THOMSON REUTERS
·
07 May

Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results

Simply Wall St.
·
02 May

Lantheus Says Alzheimer's Disease Radiodiagnostic MK-6240 Meets Primary Endpoints in Two Trials

MT Newswires Live
·
30 Apr

Lantheus Alzheimer's Diagnostic Candidate Shows Promise in Trials

Dow Jones
·
30 Apr

Lantheus announces MK-6250 study met co-primary endpoints

TIPRANKS
·
30 Apr

BRIEF-Lantheus Announces Alzheimer’s Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies

Reuters
·
30 Apr

Lantheus Holdings Inc - Nda Submission for Mk-6240 Expected in Q3 2025

THOMSON REUTERS
·
30 Apr

Lantheus Announces Alzheimer’s Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

THOMSON REUTERS
·
30 Apr

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

GlobeNewswire
·
30 Apr